important, they will rarely yield a specific diagnosis. Techniques that enable an aetiological diagnosis to be made are discussed in this article-namely, sputum induction, fibreoptic bronchoscopy with bronchoalveolar lavage or transbronchial lung biopsy, and open lung biopsy.
Before discussing these we might ask if it is important to establish an aetiological diagnosis in patients with AIDS with respiratory symptoms as nearly all will have pneumocystis pneumonia. In centres where the technique of induced sputum examination has been developed this is hardly an issue as the procedure for inducing sputum is simple and non-invasive. In centres relying on bronchoscopy to establish an aetiological diagnosis, it has been argued that most patients may be treated empirically without recourse to bronchoscopy. The advantage of this approach is that a potentially hazardous procedure for the patient is avoided and demands on the bronchoscopy and laboratory services are reduced. For some patients bronchoscopy is probably unnecessary. Some will be too ill for the procedure at presentation and others may have had previous episodes of pneumocystis pneumonia that clearly resemble the current episode. There Ultraneb 99) with a high flow rate (up to 3 ml/ min) is more efficient in inducing sputum than an ordinary jet nebuliser. A face mask is preferable to a mouthpiece because the larger saline droplets are deposited in the nose and do not irritate the trachea and larynx. The material coughed up after about 10 minutes of inhalation is mainly from the central airways and contains residual debris and usually fewer cysts than the sputum obtained later. This first sample is best discarded. Sputum obtained after a further 10 minutes of inhalation is sent for analysis and is most likely to contain material from distal airways. Purulent sputum samples are unlikely to yield P carinii and suggest a bacterial cause for the pneumonia. P carinii is usually found in clear watery specimens resembling saliva. Inexperienced laboratories may mistakenly discard such specimens as being unsuitable for analysis. Most patients tolerate the induced sputum procedure, though some find inhaling saline mist unpleasant and others develop nausea. 45 In an early study6 induced sputum was obtained before bronchoscopy and transbronchial biopsy in 43 patients with AIDS or at high risk for AIDS who presented with respiratory symptoms. The induced sputum samples were cytocentrifuged and material from the pellet was smeared on the slides and stained with silver methionine to outline the cyst walls of P carinii. Of the 20 patients shown to have pneumocystis pneumonia after bronchoscopy, 11 had a positive result from induced sputum. Furthermore, bronchoscopy did not identify any additional pathogens in those with P carinii in the induced sputum. In another study7 induced sputum was obtained from 32 patients at high risk for AIDS who had respiratory symptoms and either an abnormal chest radiograph, reduced transfer factor for carbon monoxide, or an abnormal gallium scan. Sputum samples were not cytocentrifuged but were smeared directly and processed with Giemsa to stain trophozoites and precyst forms of P carinii. These were found in 14 of the 32 patients, and in none of these was any other organism identified. The 18 patients with a negative result from induced sputum underwent bronchoscopy with bronchoalveolar lavage and transbronchial biopsy. P carinii was found in 11. In the remaining seven patients other diagnoses, including Kaposi's sarcoma, were made. The sensitivity of induced sputum in identifying P carinii was 14/25 (56%), very similar to that found by Pitchenik et al. 6 Despite these encouraging results, other centres have not been able to repeat these findings, mainly for technical reasons. Although relatively simple, the techniques require meticulous attention to detail if they are to succeed.5 Care in obtaining the sputum sample has already been mentioned. It is also important that samples reach the laboratory quickly for good results, and skilled and patient laboratory staff are required to process and examine the specimens. Indirect immunofluorescent staining of induced sputum samples using monoclonal antibodies to pneumocystis has been shown to give a higher diagnostic yield than conventional staining. A recent study9 showed a diagnostic yield of 80% with routine staining (toluidine blue 0) and 92% with immunofluorescence. The development of pneumocystis specific DNA probes may further increase the sensitivity of this technique.' 01' Induced sputum analysis is a useful diagnostic technique and in centres where it has been developed will greatly reduce the need for fibreoptic bronchoscopy. Fibreoptic bronchoscopy will continue to be necessary for patients with a negative result from induced sputum and for patients whose clinical diagnosis and response to treatment are at variance with the cytological or microbiological diagnosis obtained from induced sputum. Finally, considerable time, effort, and financial outlay is required to develop the technique of induced sputum, and this can only be justified in centres seeing a large number of patients with AIDS. In centres with few such patients bronchoscopy will remain the investigation of choice. Bronchoscopy Fibreoptic bronchoscopy is well established as a diagnostic tool for a large range of pulmonary disorders2 13 and the techniques of bronchoalveolar lavage'415 and transbronchial biopsy6 17 are widely used. Lavage was shown to be an effective method of diagnosing pneumocystis pneumonia before the AIDS epidemic.81 9 Bronchoalveolar lavage combined with transbronchial lung biopsy provides a high diagnostic yield for all the opportunist infections that affect the lung in patients with AIDS. A large retrospective series early in the AIDS epidemic reported that 910% of all pulmonary infections could be diagnosed by a combination of bronchoalveolar lavage and transbronchial lung biopsy.20 In a further study the diagnostic yields were 88% for transbronchial lung biopsy and 85 % for bronchoalveolar lavage, with a combined overall yield of 9400 .21
Other studies have supported these findings.2225 Diagnostic yields are particularly good with both techniques for P carinii. Many groups now consider that the results from lavage alone are sufficiently good to justify the omission of routine transbronchial lung biopSy2l28 not surprisingly, as bronchoalveolar lavage presumably samples many alveoli, far more than are represented in a small transbronchial biopsy specimen. Bronchoalveolar lavage alone will not, however, identify lymphocytic interstitial pneumonitis" or non-specific interstitial pneumonitis3' and these diagnoses will be missed unless transbronchial or open lung biopsy is performed.
Omission of transbronchial lung biopsy simplifies and shortens the bronchoscopic procedure and also eliminates the complications associated with transbronchial lung biopsy. When transbronchial lung biopsy is carried out via a fibreoptic bronchoscope in patients not suffering from AIDS it is safe with a low incidence of complications'7 32; but patients with AIDS undergoing transbronchial lung biopsy have an increased rate of complications-the risk appearing particularly high in patients with pneumocystis pneumonia,33 whether or not fluoroscopic screening is used.34 The reported incidence of pneumothorax has ranged from 4% to 2000 24 33 Haemorrhage is also more common and may be fatal.28
During bronchoscopy the endobronchial lesions of Kaposi's sarcoma may be seen.3536 These are either flat, resembling the submucosal haemorrhages induced by traumatic bronchoscopy, or raised, perhaps even producing partial occlusion of bronchi. Bronchial lesions of Kaposi's sarcoma are usually seen in patients with extensive lesions at other sites, particularly the skin, thus making diagnostic biopsy unnecessary. Kaposi's sarcoma is a vascular tumour, so successful biopsy of an endobronchial lesion may produce substantial haemorrhage.
The timing of fibreoptic bronchoscopy in relation to 
